BioAge Labs, Inc. (BIOA)
Nasdaq: BIOA · Pharmaceutical Preparations · Emeryville, CA · filing with the SEC since 2024
Who owns BioAge Labs, Inc.
As filed with the SECHolders of 5% or more
3
Kristen Fortney holds 7.2% of Common Stock, par value $0.00001 per share, as its SCHEDULE 13G/A filed Feb 13, 2026 says.
Directors and officers
11
report now, of 11 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Kristen Fortney
SCHEDULE 13G/A · filed Feb 13, 2026 · Common Stock, par value $0.00001 per share
Cormorant Asset Management, LP
SCHEDULE 13G/A · filed Aug 14, 2026 · Common Stock, par value $0.00001 per share · 6.51% in May 15, 2026
Blackrock, Inc.
SCHEDULE 13G · filed Apr 27, 2026 · Common Stock
VK Services, LLC
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock, par value $0.00001 per share · reported falling below 5%
RA Capital Management, L.P.
SCHEDULE 13G/A · filed Feb 14, 2025 · Common Stock, par value $0.00001 per share · reported falling below 5%
ADAR1 Capital Management, LLC
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.00001 per share · reported falling below 5%, from 5.4% in Aug 14, 2025
What BIOA reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 20, 2025.
Insider tradesForm 4
13sales
0purchases
13sales on a scheduled plan
4people selling
$7.8Msold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 15 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Fortney Kristen | Chief Executive Officer | 1 | $4.2M | 1 | 0 | $0 |
| Barton Shane | Principal Accounting Officer | 2 | $1.6M | 2 | 0 | $0 |
| Rubin Paul D | Chief Medical Officer | 6 | $1.5M | 6 | 0 | $0 |
| Goldstein Dov A Md | Chief Financial Officer | 4 | $500,000 | 4 | 0 | $0 |